![Ghislaine Gilleron](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ghislaine Gilleron
No más puestos en curso
Perfil
Ghislaine Gilleron is the founder of ElsaLys Biotech SAS, which was founded in 2013.
She worked as a Director at MiddleNext and as General Secretary & General Counsel at Transgene SA in 1985.
Ms. Gilleron completed her undergraduate degree at Institut d'Études Politiques d'Aix-en-Provence.
Antiguos cargos conocidos de Ghislaine Gilleron.
Empresas | Cargo | Fin |
---|---|---|
MiddleNext
![]() MiddleNext Miscellaneous Commercial ServicesCommercial Services MiddleNext operates as an independent business association, that provides representation of listed companies. It engages, with its members, in dialogue and lobbying to decision-makers, economic stakeholders, and financial institutions. The company was founded in 1987 and is headquartered in Paris, France. | Director/Miembro de la Junta | - |
ELSALYS BIOTECH | Fundador | - |
TRANSGENE | Consejero General | 01/01/1985 |
Formación de Ghislaine Gilleron.
Institut d'Études Politiques d'Aix-en-Provence | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
TRANSGENE | Health Technology |
Empresas privadas | 2 |
---|---|
MiddleNext
![]() MiddleNext Miscellaneous Commercial ServicesCommercial Services MiddleNext operates as an independent business association, that provides representation of listed companies. It engages, with its members, in dialogue and lobbying to decision-makers, economic stakeholders, and financial institutions. The company was founded in 1987 and is headquartered in Paris, France. | Commercial Services |
ElsaLys Biotech SAS
![]() ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology ElsaLys Biotech SAS provides therapeutic monoclonal antibody player services. It involves in cellular events at the core of the pathological process: immune response, angiogenesis, survival, proliferation, adhesion and migration. The company also designs and develops a new generation of antibodies that target tumors and their immune microenvironment. ElsaLys Biotech was founded by Christine Guillen, Thierry Menguy, Vanessa Duong, and Martine Brandt in 2013 and is headquartered in Lyon, France. | Health Technology |
- Bolsa de valores
- Insiders
- Ghislaine Gilleron